Drugs / Antigen and adjuvant level modified adjuvanted, trivalent subunit influenza vaccine
Antigen and adjuvant level modified adjuvanted, trivalent subunit influenza vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02126761 | Jun 2014 → Nov 2015 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antigen and adjuvant level modified adjuvanted, trivalent subunit influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02126761 ↗ |
| Modality | Vaccine | “Antigen and adjuvant level modified adjuvanted, trivalent subunit influenza vaccine” NCT02126761 ↗ |